TATA INDIA PHARMA AND HEALTHCARE FUND REGULAR PLAN GROWTH

NORMAL RISK
Equity
Equity: Sectoral-Pharma
6M returns
20.33 %
Current NAV
25.45
1M3M6M1Y3Y5YALL
Loading...
Min. SIP
5000
AUM
₹ 893.6 Cr

Return Calculator

Amount per month5,000
Over the past
1Y
3Y
5Y
Return amount NA
Total Investment
60,000

Investment distribution

Sun Pharmaceutical Industries12.7 %
Lupin11.2 %
Aurobindo Pharma8.7 %
Cipla6.8 %
Alkem Laboratories5.7 %
Dr. Reddy's Laboratories5.5 %

Fund Manager

Fund managers data not available.

Fund Information

Launched
11 Apr 2015(9 years ago)
Expense ratio2.32%
Exit LoadExit load of 0.25% if redeemed within 30 days.
Benchmark index
NIFTY Pharma TRI100%

Fund Objective

The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

Copyright ⓒ 2024 Cherry. All rights reserved.
appstoreplaystore